Balance Sheet

Currency: USD

	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	10	36	58	36	32	41	49	27	68	70	27	27	33
Cash Equivalents	10	36	58	36	32	41	49	27	68	70	27	27	33
Short-Term Investments	0	0	57	149	97	61	69	43	24	0	92	60	150
Total Receivables	0	2	0	1	0	1	2	0	0	0	0	0	1
Other Current Assets	0	0	1	2	1	2	2	1	5	2	2	3	11
Total Current Assets	10	37	117	188	131	105	121	72	98	72	121	90	195
PP&E Net	0	0	0	1	1	1	0	8	5	4	4	4	4
PP&E Gross	0	0	0	1	1	1	0	8	5	4	4	4	4
Accumulated Depreciation	0	0	0	0	0	1	1	1	0	1	1	1	2
Note Receivable	1	0	0	0	0	0	0	0	0	0	0	0	0
Other Long-Term Assets	0	1	0	0	0	0	0	1	2	2	2	2	1
Total Assets	11 N/A	38 +247%	118 +208%	189 +61%	132 -30%	106 -20%	122 +15%	81 -34%	105 +30%	79 -25%	126 +61%	96 -24%	200 +109%
Liabilities
Accounts Payable	1	2	2	7	3	3	4	1	3	2	2	1	2
Accrued Liabilities	2	1	3	6	4	4	4	4	6	7	9	8	22
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	0	0	1	3	3	0	5	7	0	0	0	0	0
Total Current Liabilities	3	3	7	17	10	7	13	12	9	9	11	10	24
Long-Term Debt	0	0	6	3	0	20	15	8	0	0	0	0	0
Other Liabilities	0	0	0	0	0	0	0	6	6	5	5	5	4
Total Liabilities	3 N/A	3 -1%	13 +349%	20 +53%	10 -51%	27 +176%	28 +4%	27 -5%	15 -45%	14 -5%	16 +9%	14 -8%	28 +100%
Equity
Common Stock	63	104	0	0	0	0	0	0	0	0	0	0	0
Retained Earnings	55	69	105	180	238	290	351	396	66	116	152	189	269
Additional Paid In Capital	0	0	210	349	359	368	444	450	155	181	262	270	441
Other Equity	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Equity	8 N/A	35 +337%	104 +197%	169 +62%	122 -28%	78 -36%	93 +19%	54 -43%	90 +67%	64 -28%	111 +72%	82 -26%	172 +110%
Total Liabilities & Equity	11 N/A	38 +247%	118 +208%	189 +61%	132 -30%	106 -20%	122 +15%	81 -34%	105 +30%	79 -25%	126 +61%	96 -24%	200 +109%
Shares Outstanding
Common Shares Outstanding	2	2	2	2	2	2	3	3	15	18	43	44	64

Larimar Therapeutics Inc
NASDAQ:LRMR